Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Jul;36(1):84–93. doi: 10.1038/bjc.1977.158

Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.

T C Stephens, J H Peacock, G G Steel
PMCID: PMC2025453  PMID: 889685

Abstract

The extent of tumour, cell kill, produced by treating B16 melanomas with vincristine, cyclophosphamide, 5-fluorouracil and gamma-rays, alone and in combination, was determined using an in vitro colony assay. Cell kill by vincristine was revealed as a reduction in the yield of cells obtained by trypsinization, and as a decrease in the colony-forming ability of the extracted cells. The reduction in cell yield was interpreted as evidence of rapid cell lysis. Cyclophosphamide and gamma-rays also reduced both cell yield and surviving fraction, but in this case the small decrease in cell yield was due to an increase in cell volume. FU had no effect on cell yield, but surviving fraction was reduced. Tumour weight was also measured, and used in conjunction with cell yield and surviving fraction data to calculate the fraction of surviving cells per tumour following treatment with the agents. In combination studies, single doses of two different cytotoxic agents were given either simultaneously, or up to 24 h apart in either sequence, and assays were performed 24 h after the second drug was given. Combinations of vincristine + cyclophosphamide and 5-fluorouracil + gamma-rays were chosen because they had been shown by other workers to exhibit marked schedule dependency, including considerabl potentiation, against leukaemic cell lines. However, in the B16 melanoma there was no evidence of schedule-dependent cell killing with either of these combinations. For all sequences studied, the fraction of surviving cells per tumour was slightly greater than the predicted additive response calculated from single-drug controls.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUSH R. S., BRUCE W. R. THE RADIATION SENSITIVITY OF TRANSPLANTED LYMPHOMA CELLS AS DETERMINED BY THE SPLEEN COLONY METHOD. Radiat Res. 1964 Apr;21:612–621. [PubMed] [Google Scholar]
  2. Bleehen N. M. Combination therapy with drugs and radiation. Br Med Bull. 1973 Jan;29(1):54–59. doi: 10.1093/oxfordjournals.bmb.a070957. [DOI] [PubMed] [Google Scholar]
  3. CERIOTTI G. A microchemical determination of desoxyribonucleic acid. J Biol Chem. 1952 Sep;198(1):297–303. [PubMed] [Google Scholar]
  4. Courtenay V. D. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br J Cancer. 1976 Jul;34(1):39–45. doi: 10.1038/bjc.1976.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Edelstein M., Vietti T., Valeriote F. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin. Cancer Res. 1974 Feb;34(2):293–297. [PubMed] [Google Scholar]
  7. Edelstein M., Vietti T., Valeriote F. The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate. Cancer Res. 1975 Jun;35(6):1555–1558. [PubMed] [Google Scholar]
  8. Hahn G. M., Ray G. R., Gordon L. F., Kallman R. F. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. J Natl Cancer Inst. 1973 Feb;50(2):529–533. doi: 10.1093/jnci/50.2.529. [DOI] [PubMed] [Google Scholar]
  9. Hill R. P., Stanley J. A. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Cancer Res. 1975 May;35(5):1147–1153. [PubMed] [Google Scholar]
  10. Klein H. O., Lennartz K. J. Chemotherapy after synchronization of tumor cells. Semin Hematol. 1974 Apr;11(2):203–227. [PubMed] [Google Scholar]
  11. Krishan A., Frei E., 3rd Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. Cancer Res. 1975 Mar;35(3):497–501. [PubMed] [Google Scholar]
  12. Medoff G., Schlessinger D., Kobayashi G. S. Brief communication: polyene potentiation of antitumor agents. J Natl Cancer Inst. 1973 Apr;50(4):1047–1050. doi: 10.1093/jnci/50.4.1047. [DOI] [PubMed] [Google Scholar]
  13. Medoff G., Valeriote F., Lynch R. G., Schlessinger D., Kobayashi G. S. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia. Cancer Res. 1974 May;34(5):974–978. [PubMed] [Google Scholar]
  14. Razek A., Vietti T., Valeriote F. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Cancer Res. 1974 Aug;34(8):1857–1861. [PubMed] [Google Scholar]
  15. Vietti T., Eggerding F., Valeriote F. Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells. J Natl Cancer Inst. 1971 Oct;47(4):865–870. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES